Global Somatostatin Analogs Market Report By Type (Octreotide, Lanreotide, Pasireotide), By Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11212122
April 2020
Report Formats:

The global demand for Somatostatin Analogs Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Somatostatin Analogues are drugs used in oncological treatment to inhibit the growth of tumours. These drugs when administered block the release of hormones by endocrine glands. They are generally used in patients exhibiting instability to perform a surgery or with invasive tumours. These drugs are given as injections for a period of 4 weeks. They are also used to treat a condition called acromegaly: over secretion of growth hormone in adults. Somatostatin analogues have revolutionised the treatment of neuroendocrine tumours and paediatric tumours.
 
Market Dynamics
 
The market for somatostatin analogues is mainly driven by the growing number of people affected by carcinoid tumours and hormonal disorders. The advanced health care facilities, better diagnosis and technologically advanced pharmaceutical industry will further boost the growth of this market. The various research activities carried out in the pharmaceutical industries for efficient use of these analogues will augment the market growth. Convalescing patients need to be extra careful by following social distancing during COVID-19 since they have a weak immune system. This market can be hampered by the side effects associated, prices of raw materials and stringent rules put forth by the government in the use of these drugs. Lack of awareness of these treatment methods can hinder this market as well.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of somatostatin analogs.
 
Market Segmentation
 
The entire somatostatin analogs market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Type

  • Octreotide
  • Lanreotide
  • Pasireotide
 
By Application
  • Acromegaly
  • Neuroendocrine Tumors (NETs)
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for somatostatin analogs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Somatostatin Analogs Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the somatostatin analogs market include Novartis AG, Sun Pharmaceutical Industries Ltd., MidatechPharma PLC, IpsenPharma, Chiasma, Inc., Peptron, Inc., Crinetics Pharmaceuticals, Dauntless Pharmaceuticals, Camurus AB, Teva Pharmaceuticals Inc., Pfizer Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Somatostatin Analogs Market
       2.2. Global Somatostatin Analogs Market Snapshot
 
3 . SOMATOSTATIN ANALOGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Somatostatin Analogs Market
       3.3. Market Restraints of Somatostatin Analogs Market
       3.4. Opportunities of Somatostatin Analogs Market
       3.5. Trends of Somatostatin Analogs Market
       3.6. Porter’s Five Force Analysis of Somatostatin Analogs Market
       3.7. Somatostatin Analogs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Somatostatin Analogs Value Chain Analysis
       4.2. Somatostatin Analogs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Somatostatin Analogs Raw Material Manufactures List
           4.2.3. Price Trend of Somatostatin Analogs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL SOMATOSTATIN ANALOGS MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Somatostatin Analogs Market Analysis by Type
       5.3 Market Analysis of Octreotide by Regions
       5.4 Market Analysis of Lanreotide by Regions
       5.5 Market Analysis of Pasireotide by Regions
 
6 . GLOBAL SOMATOSTATIN ANALOGS MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Somatostatin Analogs Market Analysis by Application
       6.3 Market Analysis of Acromegaly by Regions
       6.4 Market Analysis of Neuroendocrine Tumors (NETs) by Regions
       6.5 Market Analysis of Others by Regions
 
7 . GLOBAL SOMATOSTATIN ANALOGS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Somatostatin Analogs Market Estimate by Market Segment
           7.3.3. North America Somatostatin Analogs Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Somatostatin Analogs Market Estimate by Market Segment
           7.4.3. Europe Somatostatin Analogs Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Somatostatin Analogs Market Estimate by Market Segment
           7.5.3. Asia Pacific Somatostatin Analogs Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Somatostatin Analogs Market Estimate by Market Segment
           7.6.3. Latin America Somatostatin Analogs Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Somatostatin Analogs Market Estimate by Market Segment
           7.7.3. Middle East & Africa Somatostatin Analogs Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE SOMATOSTATIN ANALOGS COMPANIES
       8.1. Somatostatin Analogs Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF SOMATOSTATIN ANALOGS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Novartis AG
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Sun Pharmaceutical Industries Ltd
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. MidatechPharma PLC
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. IpsenPharma
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Chiasma, Inc.
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Peptron, Inc.
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. CRINETICS PHARMACEUTICALS
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Dauntless Pharmaceuticals
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Camurus AB
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Teva Pharmaceuticals Inc.
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
       9.13. Pfizer Inc.
           9.13.1. Company Overview
           9.13.2. Financials
           9.13.3. Products
           9.13.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Somatostatin Analogs Market Snapshot
  • Drivers of The Global Somatostatin Analogs Market Impact Analysis
  • Restraints of The Global Somatostatin Analogs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Somatostatin Analogs Market Analysis by Type (USD MN)
  • Global Somatostatin Analogs Market Analysis in Octreotide by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis in Lanreotide by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis in Pasireotide by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis by Application (USD MN)
  • Global Somatostatin Analogs Market Analysis in Acromegaly by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis in Neuroendocrine Tumors (NETs) by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis in Others by Geography (USD MN)
  • Global Somatostatin Analogs Market by Geography (USD MN)
  • North America Somatostatin Analogs Market Analysis by Type (USD MN)
  • North America Somatostatin Analogs Market Estimate by Application (USD MN)
  • North America Somatostatin Analogs Market Estimate by Country (USD MN)
  • United State Somatostatin Analogs Market Analysis by Type (USD MN)
  • United State Somatostatin Analogs Market Estimate by Application (USD MN)
  • Rest of North America Somatostatin Analogs Market Analysis by Type (USD MN)
  • Rest of North America Somatostatin Analogs Market Estimate by Application (USD MN)
  • Europe Somatostatin Analogs Market Analysis by Type (USD MN)
  • Europe Somatostatin Analogs Market Estimate by Application (USD MN)
  • United Kingdom Somatostatin Analogs Market Analysis by Type (USD MN)
  • United Kingdom Somatostatin Analogs Market Estimate by Application (USD MN)
  • France Somatostatin Analogs Market Analysis by Type (USD MN)
  • France Somatostatin Analogs Market Estimate by Application (USD MN)
  • Germany Somatostatin Analogs Market Analysis by Type (USD MN)
  • Germany Somatostatin Analogs Market Estimate by Application (USD MN)
  • Rest of Europe Somatostatin Analogs Market Analysis by Type (USD MN)
  • Rest of Europe Somatostatin Analogs Market Estimate by Application (USD MN)
  • Asia Pacific Somatostatin Analogs Market Analysis by Type (USD MN)
  • Asia Pacific Somatostatin Analogs Market Estimate by Application (USD MN)
  • Asia Pacific Somatostatin Analogs Market Estimate by Country (USD MN)
  • China Somatostatin Analogs Market Analysis by Type (USD MN)
  • China Somatostatin Analogs Market Estimate by Application (USD MN)
  • Japan Somatostatin Analogs Market Analysis by Type (USD MN)
  • Japan Somatostatin Analogs Market Estimate by Application (USD MN)
  • India Somatostatin Analogs Market Analysis by Type (USD MN)
  • India Somatostatin Analogs Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Somatostatin Analogs Market Analysis by Type (USD MN)
  • Rest of Asia Pacific Somatostatin Analogs Market Estimate by Application (USD MN)
  • Latin America Somatostatin Analogs Market Analysis by Type (USD MN)
  • Latin America Somatostatin Analogs Market Estimate by Application (USD MN)
  • Latin America Somatostatin Analogs Market Estimate by Country (USD MN)
  • Brazil Somatostatin Analogs Market Analysis by Type (USD MN)
  • Brazil Somatostatin Analogs Market Estimate by Application (USD MN)
  • Rest of Latin America Somatostatin Analogs Market Analysis by Type (USD MN)
  • Rest of Latin America Somatostatin Analogs Market Estimate by Application (USD MN)
  • Middle East & Africa Somatostatin Analogs Market Analysis by Type (USD MN)
  • Middle East & Africa Somatostatin Analogs Market Estimate by Application (USD MN)
  • Middle East & Africa Somatostatin Analogs Market Estimate by Country (USD MN)
  • Middle East Somatostatin Analogs Market Analysis by Type (USD MN)
  • Middle East Somatostatin Analogs Market Estimate by Application (USD MN)
  • Africa Somatostatin Analogs Market Analysis by Type (USD MN)
  • Africa Somatostatin Analogs Market Estimate by Application (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Somatostatin Analogs Report
  • Market Research Process
  • Market Research Methodology
  • Global Somatostatin Analogs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Somatostatin Analogs Market Analysis by Type (USD MN)
  • Global Somatostatin Analogs Market Analysis in Octreotide by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis in Lanreotide by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis in Pasireotide by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis by Application (USD MN)
  • Global Somatostatin Analogs Market Analysis in Acromegaly by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis in Neuroendocrine Tumors (NETs) by Geography (USD MN)
  • Global Somatostatin Analogs Market Analysis in Others by Geography (USD MN)
  • Latin America Somatostatin Analogs Market by Revenue
  • Middle East & Africa Somatostatin Analogs Market by Revenue
  • Recent Development in Somatostatin Analogs Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials